SciVision Biotech Inc.(TW:1786)
NT$52.000.00 (0.00%)
TW:1786
SciVision Biotech Inc. Revenue
NT$52.00
At close:0.00 (0.00%)
SciVision Biotech Inc. (1786) Revenue
SciVision Biotech Inc. Revenue
SciVision Biotech Inc. had a revenue of 211.03M in the quarter ending Jun 30, 2026, with 2.78%. This bring the company's revenue in the last twelve months to 889.15M, Increased 0.17%. In the fiscal year ending Dec 31, 2025, SciVision Biotech Inc. had annual revenue of 886.62M with 0.37% growth.
- Revenue (ttm)
- 889.15M
- Revenue Growth
- -2.25%
- P/S Ratio
- 4.39
- Revenue/Employee
- TWD 455,379
- Employees
- 1,947
- Market Cap
- TWD 3.89B
Revenue Chart
SciVision Biotech Inc. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 886.62M | 3.31M | 0.37% |
| Dec 31, 2024 | 883.31M | 170.32M | 23.89% |
| Dec 31, 2023 | 712.99M | 155.64M | 27.93% |
| Dec 31, 2022 | 557.35M | 51.81M | 10.25% |
| Dec 31, 2021 | 505.54M | 38.66M | 8.28% |
| Dec 31, 2020 | 466.88M | 29.01M | 6.62% |
| Dec 31, 2019 | 437.87M | 108.29M | 32.86% |
| Dec 31, 2018 | 329.58M | 71.16M | 27.54% |
| Dec 31, 2017 | 258.42M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.